Sexually transmitted infections

>

Latest News

Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial
Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial

April 15th 2025

Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Universal Syphilis Screening in the ED Outperforms Targeted Approaches: Daily Dose / image credit: ©New Africa/AdobeStock
Universal Syphilis Screening in the ED Outperforms Targeted Approaches: Daily Dose

April 4th 2025

FDA logo ©Araki Ilustrations/AdobeStock
FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis

March 31st 2025

New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted

March 28th 2025

Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation / Image credit: ©Dr_Microbe - ©Dr_Microbe - stock.adobe.com
Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation

March 26th 2025

Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.